{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:13:26Z","timestamp":1753892006233,"version":"3.41.2"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to investigate the effect of antiresorptive agents on the ossification of reconstructed mandibles by free bone grafts for the first time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 38 reconstructions of the jaw were retrospectively evaluated for ossification between bone segments by two raters based on postoperative panoramic radiographs. The study group (n = 13) had segmental resection of the mandible and free bone flap reconstruction due to medication-related osteonecrosis of the jaw (MRONJ). The control group (noMRONJ, n = 25) comprised segmental mandibular resections and free bone flap reconstructions due to tumors, chronic osteomyelitis, or trauma without any radiation. Ossification time and influencing factors were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both duration of surgery (346 \u00b1 90\u00a0min. vs. 498 \u00b1 124\u00a0min.; p &amp;lt; 0.001) and hospitalization (8.7 \u00b1 2.8 days vs. 13.4 \u00b1 5.3 days, p = 0.006) were shorter in the MRONJ group compared to the noMRONJ group. Ossification after mandibular reconstruction was significantly faster in the MRONJ study group [224 days, interquartile range (IQR) 175\u2013287] compared to the control group (288 days, IQR 194\u2013445; p &amp;lt; 0.001). Moreover, good initial contact between the segments resulted in faster ossification (p &amp;lt; 0.001) in the MRONJ group. Ossification rate between original and grafted bone or between grafted bone segments only did not differ in both the study and control groups (MRONJ, p = 0.705 vs. control, p = 0.292). The type of antiresorptive agent did not show any significance for ossification. The rate of wound healing disturbances did also not differ between the study and control groups (p = 0.69).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Advanced MRONJ (stage 3) can be resected and reconstructed safely with free microvascular bone flaps. Antiresorptive agents enhance the ossification of the bone segments. Optimal initial contact of the bone segments accelerates bone healing. Surgery and hospitalization are markedly shortened in this vulnerable group of MRONJ patients compared to oncologic patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1401165","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:51:32Z","timestamp":1718185892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiresorptive agents enhance ossification of free flap reconstructions of the mandible: a radiological retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Maximilian","family":"Gottsauner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Eichberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Eckm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schuderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten E.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Ettl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808063390601","article-title":"Reduction in new metastases in breast cancer with adjuvant clodronate treatment","volume":"339","author":"Diel","year":"1998","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"Cd003474","DOI":"10.1002\/14651858.CD003474.pub4","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"10","author":"O'Carrigan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105792","DOI":"10.1016\/j.archoralbio.2023.105792","article-title":"Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects","volume":"155","author":"Nogueira","year":"2023","journal-title":"Arch Oral Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar2167","article-title":"Role of RANKL inhibition in osteoporosis","volume":"9","author":"McClung","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100507","DOI":"10.1016\/j.jbo.2023.100507","article-title":"The low and disproportionate utilization of antiresorptive therapy in patients with osseous metastasis","volume":"43","author":"Agarwal","year":"2023","journal-title":"J Bone Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17256","article-title":"Controversies in the use of new bone-modifying therapies in multiple myeloma","volume":"193","author":"Terpos","year":"2021","journal-title":"Br J Haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06473-0","article-title":"The imminent risk of a fracture-existing worldwide data: a systematic review and meta-analysis","volume":"33","author":"Wong","year":"2022","journal-title":"Osteoporos Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/2042098611411012","article-title":"Safety of drugs used in the treatment of osteoporosis","volume":"2","author":"Mcgreevy","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","article-title":"Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management","volume":"60","author":"Ruggiero","year":"2009","journal-title":"Annu Rev Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J Clin Densitom"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2013.12.007","article-title":"Management of antiresorptive osteonecrosis of the jaws with primary surgical resection","volume":"72","author":"Carlson","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2018.03.005","article-title":"Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study","volume":"46","author":"Ristow","year":"2018","journal-title":"J Craniomaxillofac Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2017.01.023","article-title":"Surgical resection and vascularized bone reconstruction in advanced stage medication-related osteonecrosis of the jaw","volume":"46","author":"Caldroney","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9858921","DOI":"10.1155\/2018\/9858921","article-title":"Microsurgical reconstruction of the jaws using vascularised free flap technique in patients with medication-related osteonecrosis: A systematic review","volume":"2018","author":"Sacco","year":"2018","journal-title":"BioMed Res Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2013.4474","article-title":"Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws","volume":"139","author":"Hanasono","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24395","article-title":"Resection and microvascular reconstruction of bisphosphonate-related osteonecrosis of the jaw: The role of microvascular reconstruction","volume":"38","author":"Neto","year":"2016","journal-title":"Head Neck"},{"key":"B20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00006534-198909000-00001","article-title":"Orofacial and mandibular reconstruction with the iliac crest free flap: a review of 60 cases and a new method of classification","volume":"84","author":"Jewer","year":"1989","journal-title":"Plast Reconstr Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2012.170","article-title":"Long-term effects of alendronate on fracture healing and bone remodeling of femoral shaft in ovariectomized rats","volume":"34","author":"Fu","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2010.07.063","article-title":"Effects of zoledronic acid on healing of mandibular fractures: an experimental study in rabbits","volume":"69","author":"Tatli","year":"2011","journal-title":"J Oral Maxillofac Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1383(16)30015-8","article-title":"How do bisphosphonates affect fracture healing","volume":"47","author":"Kates","year":"2016","journal-title":"Injury"},{"key":"B24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40902-022-00366-2","article-title":"Reconstruction of mandibular defects in osteoradionecrosis and medication-related osteonecrosis of the jaw using fibula free flap and management of postoperative wound infections","volume":"44","author":"Oh","year":"2022","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175041","article-title":"Influence of radiotherapy on ossification of vascularized osseous reconstruction of the jaw: A radiological retrospective cohort study based on panoramic radiographs","volume":"11","author":"Gottsauner","year":"2022","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820931069","article-title":"Natural history and consequences of nonunion in mandibular and maxillary free flaps","volume":"163","author":"Swendseid","year":"2020","journal-title":"Otolaryngology\u2013Head Neck Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.oraloncology.2018.07.004","article-title":"Accuracy of computer-assisted surgery in mandibular reconstruction: A systematic review","volume":"84","author":"van Baar","year":"2018","journal-title":"Oral Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235774","article-title":"Osseous Union after Jaw Reconstruction with Fibula-Free Flap: Conventional vs. CAD\/CAM Patient-Specific Implants","volume":"14","author":"Knitschke","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000008085","article-title":"Computer-aided design and manufacturing versus conventional surgical planning for head and neck reconstruction: A systematic review and meta-analysis","volume":"148","author":"Padilla","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2904-5","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Support Care Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2021.822411","article-title":"A review into the effects of pamidronic acid and zoledronic acid on the oral mucosa in medication-related osteonecrosis of the jaw","volume":"2","author":"Bullock","year":"2021","journal-title":"Front Oral Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165206","article-title":"Risk factors for flap loss: analysis of donor and recipient vessel morphology in patients undergoing microvascular head and neck reconstructions","volume":"12","author":"Schuderer","year":"2023","journal-title":"J Clin Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1401165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T09:51:35Z","timestamp":1718185895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1401165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":33,"alternative-id":["10.3389\/fonc.2024.1401165"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1401165","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"article-number":"1401165"}}